- ASSISTANT PROFESSOR Medicine, Clinical Immunology
Postdoctoral Fellow, McGill University
Ph.D., University of Nantes
Cellular and Molecular Biology
M.S., University of Burgundy
Biochemistry and Molecular Biology
M.S., Lebanese University
Microbiology and Immunology
New topicResearch coordinator/Lab Manager: Dominique Bozec, M.S.
Graduate Student: Luciana Muniz PhD student [IMM]
Postdoctoral Fellows: Mansi Saxena, Ph.D.; Marianna Parlato, Ph.D.
Our laboratory studies signaling pathways regulating innate immunity and cell death. The research focus is to elucidate the molecular mechanisms and roles of cytosolic pattern recognition receptors of the Nod-like receptor (NLR) family in host defense, chronic inflammation and cancer.
Several established approaches, ranging from genetically modified mouse models to biochemistry and cellular immunology methods, are used in our laboratory to gain insight into the mechanisms that govern host-pathogen interactions, tumor biology and inflammatory-mediated immune disorders.
We are particularly investigating the functions of various apoptosis effectors in infection, inflammatory bowel diseases and colorectal cancer.
Postdoctoral and graduate projects are regularly available.
Visit the Yeretssian Lab homepage at:
Roda G., Jianyu X., Park M., Hovhannisyan Z., Couri R., Stanners C., Yeretssian G., Mayer L. Characterizing CEACAM5 interaction with CD8α and CD1d in intestinal homeostasis. Mucosal Immunology 2013; Oct 9. doi: 10.1038/mi.2013.80.
Meunier C., Van Der Kraak L., Turbide C., Groulx N., Labouba I., Cingolani P., Blanchette M., Yeretssian G., Mes-Masson AM., Saleh M., Beauchemin N., Gros P. Positional mapping and candidate gene analysis of the mouse ccs3 locus that regulates differential susceptibility to carcinogen-induced colorectal cancer. PLOS One 2013; 8: e58733.
Muniz LR., Knosp C., Yeretssian G. Intestinal antimicrobial peptides during homeostasis, infection and disease. Frontiers in Immunology 2012; 3:310.
Yeretssian G. Effector functions of NLRs in the intestine: innate sensing, cell death, and disease. Immunologic Research 2012; 54 (1-3):25-36.
Yeretssian G., Correa RC., Doiron K., Fitzgerald P., Dillon CP., Green DR., Reed JC., Saleh M. Non- apoptotic role of BID in inflammation and innate immunity. Nature 2011, 474(7349): 96-9.
Labbe K., *Miu J., *Yeretssian G., Serghides L., Tam M., Finney CA., Erdman LK., Goulet ML., Kain KC., Stevenson MM., Saleh M. Caspase-12 dampens the immune response to malaria independently of the inflammasome by targeting NF-kB signaling. Journal of Immunology 2010, 185(9): 5495-502. *(Shared second authorship)
*Dupaul-Chicoine J., *Yeretssian G., Doiron K., Bergstrom KS., McIntire CR., LeBlanc PM., Meunier C., Turbide C., Gros P., Beauchemin N., Vallance BA., Saleh M. Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases. Immunity 2010, 32(3):367-78. *(Shared first authorship)
Yeretssian G., Doiron K., Shao W., Leavitt BR., Hayden MR., Nicholson DW., Saleh M. Gender differences in expression of the human caspase-12 long variant determines susceptibility to Listeria monocytogenes infection. Proceedings of the National Academy of Science 2009, 106(22): 9016-20.
*McIntire CR., *Yeretssian G., Saleh M. Inflammasomes in infection and inflammation. Apoptosis 2009, 14(4): 522-35. *(Shared first authorship)
Yeretssian G., Labbe K., Saleh M. Molecular regulation of inflammation and cell death. Cytokine 2008, 43(3):380-90.
LeBlanc PM., Yeretssian G., Rutherford N., Doiron K., Nadiri A., Zhu L., Green DR., Gruenheid S., Saleh M. Caspase-12 modulates NOD signaling and regulates antimicrobial peptide production and mucosal immunity. Cell Host and Microbe 2008, 13; 3(3): 146-57.
Gaudin JC., Rabesona H., Choiset Y., Yeretssian G., Chobert JM., Sakanyan V., Haertle T. Assessment of the IgE-mediated immune response to milk-specific proteins in allergic patients using microarrays. Clinical and Experimental Allergy 2008, 38(4): 686-93.
Shao W., Yeretssian G., Doiron K., Hussain SN., Saleh M. The caspase-1 digestome identifies the glycolysis pathway as a caspase-1 target during Salmonella infection and in septic shock. Journal of Biological Chemistry 2007, 282(50): 36321-9.
Yeretssian G., Lecocq M., Lebon G., Hurst H.C., Sakanyan V. Competition on nitrocellulose immobilized antibody arrays: From bacterial protein binding assay to protein profiling in breast cancer cells. Molecular and Cellular Proteomics 2005, 4(5), 605-617.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Yeretssian did not report having any of the following types of financial relationships with industry during 2012 and/or 2013: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
Icahn Medical Institute Floor 12 Room 12-20
1425 Madison Avenue
New York, NY 10029
Icahn Medical Institute Floor 12th floor Room 12-20E
1425 Madison Avenue
New York, NY 10029